Alangcas, Ace D.
HRN: 27-11-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/07/2025
05/14/2025
PO
6.5mL
TID
AMOEBIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes